News & Events

During Heart Month, OneOme Highlights How RightMed® Pharmacogenomic Test Can Help People Taking Heart Medications

RightMed Pharmacogenomic Test is a New Way for Your Physician to Improve the Effectiveness of Your Cardiovascular Prescriptions

MINNEAPOLIS (Feb. 1, 2017) – This Heart Month, people suffering from heart conditions have a new opportunity to improve the effectiveness of their cardiovascular treatments through their healthcare provider: OneOme’s RightMed pharmacogenomic test. The RightMed test uses the power of DNA to minim...


Pharmacogenomics Company OneOme Announces Leadership Promotions

Jason Ross will Serve as Chief Technology Officer, Josiah Allen Promoted to Director of Medical Affairs

MINNEAPOLIS (Jan. 26, 2017) – Pharmacogenomics company OneOme announced today that Jason Ross will serve as its chief technology officer and that Josiah Allen was promoted to OneOme’s director of medical affairs.

“We are glad to add Josiah Allen and Jason Ross to our leadership team,” said Pa...


Pharmacogenomics Company OneOme Announces Patent-Pending Status for RightMed® Test and RightMed Advisor

MINNEAPOLIS (Jan. 10, 2017) – Pharmacogenomics company OneOme today announced the U.S. Patent and Trademark office has issued “Patent Pending” status for its RightMed pharmacogenomic test and RightMed Advisor, an online tool for providers to quickly and easily interpret test results and gain a...


OneOme Receives Laboratory Clinical Certification from Five States

Certification Reaffirms OneOme’s High Standards of Laboratory Quality

MINNEAPOLIS (Jan. 9, 2017) – Twin Cities-based pharmacogenomics company OneOme announced today that it has earned laboratory certification in California, Florida, Maryland, Pennsylvania, and Rhode Island. These certifications affirm OneOme’s commitment to exceeding the specific clinical laborato...


How your DNA has the potential to help you avoid the wrong medications

How your DNA has the potential to help you avoid the wrong medications.
Did you know more than half of the 4 billion prescriptions written in America this year will not work as intended (IMS, Trends Mol. Med. 2001)? It’s true, and the answer to why that’s the case lies in our DNA.